Mild cooling of the ear during cochlear implant surgery to protect remaining hearing
Tests ear cooling during cochlear implant surgery in adults with hearing loss.
Key facts
- Who runs it
- Restorear Devices LLC
- Where
- Miami, United StatesSee the site
- Trial code
- Registry title
- Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
- Status
- Recruiting
- People taking part
- 54 people, planned
- Started
- 23 Sept 2024
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Intra-Ear Canal Cooling Catheter
- Record updated
- 23 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe to profound hearing loss who plan to get a cochlear implant at the University of Miami. Some will get mild cooling of the ear during surgery to try to protect the hearing they still have.
- Age
- 18 years and older
- Sex
- Men and women, in equal numbers
- Disease stage
- Severe to profound hearing loss caused by an inner ear or nerve problem (sensorineural). The safety part needs profound hearing loss. The efficacy part needs some remaining hearing on a pre-surgery brainstem hearing test (ABR).
- Earlier treatment
- People must be planning cochlear implant surgery with a device from Advanced Bionics, Cochlear Corporation or Med-EL.
- Biomarker or test result
- Remaining hearing shown on a pre-surgery auditory brainstem response (ABR) test, for the efficacy part.
Main reasons for not taking part
- People under 18 years of age
- People who do not meet the hearing requirements
- People who do not speak English or Spanish
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Potential participants for the study are patients who have been diagnosed with severe to profound hearing loss (HL) and plan to undergo cochlear implantation (CI) at the University of Miami. The cochlear implant surgery, pre and post-surgical care, and activation and programming of the implant are part of the participants' standard of care. If the inclusion criteria are met (age 18 years and older, equal number of men and women, profound sensorineural hearing loss (for safety study n=6) and residual hearing (see criteria below) from pre-surgical auditory brainstem response (ABR) (for efficacy study n=48), equal numbers of CI devices from all 3 manufactures and English or Spanish speakers the patient will be approached by the study personnel and will be asked to participate in the study
Who cannot take part
- The study will enroll patients receiving CI devices from all three manufactures
- Med-EL (moderately-severe to severe sensorineural hearing loss (greater than or equal to 65 db HL); Synchrony 2 Flex soft; Synchrony 2 Flex28; Synchrony 2 Flex 24; Synchrony 2 Compressed; Synchrony 2 Medium; Additional patients receiving devices not listed here may be eligible as the criteria by manufacturer change
- Subjects under 18 years of age. Subjects not meeting functional hearing requirements
- Types of CI devices:
- Advanced Bionics (FDA indications - severe to profound sensorineural hearing loss (greater than or equal to 70 dB HL); HiRes Ultra 3D slim J; HiRes Ultra 3D midScala
- Cochlear Corporation (FDA indications - moderate to profound sensorineural hearing loss; sentence recognition less than or equal to 50% in the ear to be implanted AND less than or equal to 60% in the contralateral ear; CI632; CI622; CI612
Where in United States
- University of MiamiMiami, United StatesContact: Suhrud M Rajguru, Ph.D.Taking people
About the trial
What the trial wants to find out
The goal of this interventional clinical study is to investigate the use of mild therapeutic hypothermia for preservation of residual hearing in cochlear implant surgery. The main questions the trial aims to answer are:
Read full original descriptionShow less
1. Is mild therapeutic hypothermia safe for use during cochlear implantation? 2. Is mild therapeutic hypothermia effective at preserving residual hearing after cochlear implantation?
Participants will receive mild therapeutic hypothermia therapy during cochlear implant surgery. Researchers will compare results from those receiving the therapy to those from a control group (individuals receiving no therapy).
The 3 groups in the trial
- Safety StudyTreatment being tested
Aim 1: Ascertain the safety of the system and device in patients undergoing cochlear implantation (CI). Mild therapeutic hypothermia will be delivered to the subjects during CI surgery via the ear canal.
Treatment: Intra-Ear Canal Cooling Catheter
- Efficacy Study CoolingTreatment being tested
Aim 2: Ascertain the applicability and efficacy of the device and system in patients undergoing cochlear implantation (CI). Half of the candidates will receive mild therapeutic hypothermia via the ear canal during cochlear implant surgery.
Treatment: Intra-Ear Canal Cooling Catheter
- Efficacy Study ControlNo study treatment, for comparison
Aim 2: Ascertain the applicability and efficacy of the device and system in patients undergoing cochlear implantation (CI). Half of the candidates will receive standard of care (no cooling) during cochlear implant surgery.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
- Plain-language title
- Mild cooling of the ear during cochlear implant surgery to protect remaining hearingGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 23 July 2026